MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression

Oncology Letters
|June 20, 2022
PubMed

Insights

This article has been retracted. The original study, identified by DOI 10.3892/ol.2017.7201, is no longer considered valid scientific literature.

Area of Science:

  • Retraction notices
  • Scientific integrity

Context:

  • The article identified by DOI 10.3892/ol.2017.7201 has been retracted.
  • This action impacts the scientific record and requires careful attention from researchers.

Purpose:

  • To formally announce the retraction of a specific scientific publication.
  • To inform the scientific community about the invalidation of the article's findings.

Summary:

  • The scientific article with DOI 10.3892/ol.2017.7201 is officially retracted.
  • This retraction signifies that the content of the article is no longer considered reliable or valid.

Impact:

  • Ensures the accuracy and reliability of the scientific literature.
  • Maintains trust in published research by addressing issues with previously published work.